CERo Therapeutics Holdings, Inc. (CERO) Earning

$0.06

south_east -$0 (-3.85%)
Day's range
$0.06
Day's range
$0.06

CERo Therapeutics Holdings, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/19/2024 Q3 2024 -$0.09 $0
08/14/2024 Q2 2024 -$0.15 $0
03/29/2024 Q1 2024 -$0.16 $0
12/29/2023 Q4 2023 -$0.05 $0
09/28/2023 Q3 2023 -$0.05 $0
06/28/2023 Q2 2023 -$0.21 $0
03/30/2023 Q1 2023 -$0.07 $0
12/29/2022 Q4 2022 -$0.04 $0
09/28/2022 Q3 2022 $0.00 $0
06/28/2022 Q2 2022 -$0.00 $0
03/29/2022 Q1 2022 -$0.02 $0
12/29/2021 Q4 2021 -$0.01 $0
06/30/2021 Q2 2021 -$0.00 $0
 

CERo Therapeutics Holdings, Inc. Earnings: FAQ's

When is CERo Therapeutics Holdings, Inc.'s earnings date?

CERo Therapeutics Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.

How can I listen to CERo Therapeutics Holdings, Inc.'s earnings conference call?

The conference call for CERo Therapeutics Holdings, Inc.'s latest earnings report can be listened to online.

How can I read CERo Therapeutics Holdings, Inc.'s conference call transcript?

The conference call transcript for CERo Therapeutics Holdings, Inc.'s latest earnings report can be read online.

How much profit does CERo Therapeutics Holdings, Inc. generate each year?

CERo Therapeutics Holdings, Inc. (:CERO) has a recorded net income of $0. CERo Therapeutics Holdings, Inc. has generated $-0.39 earnings per share over the last four quarters.

What is CERo Therapeutics Holdings, Inc.'s price-to-earnings ratio?

CERo Therapeutics Holdings, Inc. (:CERO) has a price-to-earnings ratio of -0.32 and price/earnings-to-growth ratio is 0.04.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED